Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Brazil
  4. Bolsa de Valores de Sao Paulo
  5. Fleury S.A.
  6. News
  7. Summary
    FLRY3   BRFLRYACNOR5

FLEURY S.A.

(FLRY3)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Fleury to Seek Acquisitions

07/30/2021 | 10:00am EDT

Fleury S.A. (BOVESPA:FLRY3) will look for acquisitions. Fernando Augusto Leao Filho Chief Financial Officer & IRO said, "the company will focus on growth through M&A, and we think there is a lot of space for that".


ę S&P Capital IQ 2021
All news about FLEURY S.A.
10/18Fleury S.A. entered into a purchase agreement to acquire Laboratorio Marcelo Magalhaes ..
CI
07/30Fleury to Seek Acquisitions
CI
07/29Fleury S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
07/29FLEURY S A : Earnings Release - 2Q21
PU
07/29FLEURY S A : Financial Statements - 2Q21
PU
06/24FLEURY S A : Comunicado ao Mercado
PU
04/30Fleury to Seek Acquisitions
CI
04/29FLEURY S A : Financial Statements - 1Q21
PU
04/29Fleury S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
02/25Fleury S.A. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
More news
Financials
Sales 2021 3 557 M 630 M 630 M
Net income 2021 347 M 61,5 M 61,5 M
Net Debt 2021 1 862 M 330 M 330 M
P/E ratio 2021 17,5x
Yield 2021 4,95%
Capitalization 6 181 M 1 076 M 1 094 M
EV / Sales 2021 2,26x
EV / Sales 2022 2,08x
Nbr of Employees 15 000
Free-Float 54,8%
Chart FLEURY S.A.
Duration : Period :
Fleury S.A. Technical Analysis Chart | FLRY3 | BRFLRYACNOR5 | MarketScreener
Technical analysis trends FLEURY S.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 19,50 BRL
Average target price 28,61 BRL
Spread / Average Target 46,7%
EPS Revisions
Managers and Directors
Jeane Mike Tsutsui Chief Executive Officer
JosÚ Ant˘nio de Almeida Filippo Director-Finance & Investor Relations
Marcio Pinheiro Mendes Chairman
Edgar Gil Rizzatti Head-Medical, Technical & Process
Andrea Cristina de Lima Rolim Independent Director
Sector and Competitors
1st jan.Capi. (M$)
FLEURY S.A.-27.83%1 076
SONIC HEALTHCARE LIMITED23.27%14 201
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.-23.94%7 061
NEOGENOMICS, INC.-16.62%5 520
DR. LAL PATHLABS LIMITED46.84%3 734
FULGENT GENETICS, INC.61.34%2 482